Immunomodulation of Helicobacter Infection

Helicobacter pylori leads to a chronic infection in humans that is associated with gastric inflammation and a vigorous immune response. Despite the humoral and cellular responses that can be detected in both human and animal models of helicobacter infection, the immune response fails to eliminate th...

Full description

Saved in:
Bibliographic Details
Main Author: Ken Croitoru
Format: Article
Language:English
Published: Wiley 1999-01-01
Series:Canadian Journal of Gastroenterology
Online Access:http://dx.doi.org/10.1155/1999/839194
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850109916674523136
author Ken Croitoru
author_facet Ken Croitoru
author_sort Ken Croitoru
collection DOAJ
description Helicobacter pylori leads to a chronic infection in humans that is associated with gastric inflammation and a vigorous immune response. Despite the humoral and cellular responses that can be detected in both human and animal models of helicobacter infection, the immune response fails to eliminate the organism. Eradication failure may be due to the niche in which H pylori confines itself, well away from direct contact with elements of the immune system. Alternatively, the general tendency of the intestinal immune response to down- regulate reactivity to noninvasive luminal bacteria also may contribute to the failure to eliminate helicobacter infection. Results of vaccine studies in mouse models indicate that modulating the helper T cell response from a T helper cell type 1 to a T helper cell type 2 response likely is required for the prevention and elimination of helicobacter infection. Understanding the mechanisms by which the immune response controls bacterial infections will allow for the design of novel strategies of immune modulation and the development of vaccines for both the treatment and prevention of H pylori.
format Article
id doaj-art-43338a821cfb4ed286c8e5ca3c1361c2
institution OA Journals
issn 0835-7900
language English
publishDate 1999-01-01
publisher Wiley
record_format Article
series Canadian Journal of Gastroenterology
spelling doaj-art-43338a821cfb4ed286c8e5ca3c1361c22025-08-20T02:37:57ZengWileyCanadian Journal of Gastroenterology0835-79001999-01-0113323724110.1155/1999/839194Immunomodulation of Helicobacter InfectionKen Croitoru0Intestinal Diseases Research Program, Department of Medicine, Division of Gastroenterology, McMaster University, Hamilton, Ontario, CanadaHelicobacter pylori leads to a chronic infection in humans that is associated with gastric inflammation and a vigorous immune response. Despite the humoral and cellular responses that can be detected in both human and animal models of helicobacter infection, the immune response fails to eliminate the organism. Eradication failure may be due to the niche in which H pylori confines itself, well away from direct contact with elements of the immune system. Alternatively, the general tendency of the intestinal immune response to down- regulate reactivity to noninvasive luminal bacteria also may contribute to the failure to eliminate helicobacter infection. Results of vaccine studies in mouse models indicate that modulating the helper T cell response from a T helper cell type 1 to a T helper cell type 2 response likely is required for the prevention and elimination of helicobacter infection. Understanding the mechanisms by which the immune response controls bacterial infections will allow for the design of novel strategies of immune modulation and the development of vaccines for both the treatment and prevention of H pylori.http://dx.doi.org/10.1155/1999/839194
spellingShingle Ken Croitoru
Immunomodulation of Helicobacter Infection
Canadian Journal of Gastroenterology
title Immunomodulation of Helicobacter Infection
title_full Immunomodulation of Helicobacter Infection
title_fullStr Immunomodulation of Helicobacter Infection
title_full_unstemmed Immunomodulation of Helicobacter Infection
title_short Immunomodulation of Helicobacter Infection
title_sort immunomodulation of helicobacter infection
url http://dx.doi.org/10.1155/1999/839194
work_keys_str_mv AT kencroitoru immunomodulationofhelicobacterinfection